Abstract: A series of novel benzothiazole-2-thiol derivatives were synthesized and their structures determined by 1 H-NMR,
Introduction
A number of benzothiazole derivatives have exhibited interesting biological activities [1] [2] [3] and attracted continuing interest for further molecular exploration as useful anticancer agents [4, 5] . Our preceding studies had found that two benzothiazole-2-thiol compounds (compounds 1 and 2) displayed good anticancer activities and induced HepG2 cell apoptosis in vitro [6] . In order to develop more potent tumor growth inhibitors as novel anticancer agents, we designed and synthesized a series of novel benzothiazole-2-thiol derivatives through incorporation of heterocyclic rings (pyridine, pyrimidine and thiazole) to benzothiazole-2-thiol derivatives with the activity and safety advantages of the OPEN ACCESS heterocyclic ring structures [7, 8] . The effects of all the novel compounds on a panel of different types of human cancer cell lines were investigated by the MTT assay and compound 7e was selected to examine apoptosis on HepG2 cell cells by flow cytometry. As a result, the pyridinyl-2-amine linked benzothiazole-2-thiol compounds exhibited potent anticancer activities and compound 7e inhibited the proliferation of HepG2 cell via inducing apoptosis.
Results and Discussion

Chemistry
Twenty novel benzothiazole-2-thiol derivatives linked with heterocyclic rings were designed and synthesized by the route shown in Scheme 1.
Scheme 1. Synthetic route for 7a-t.
Reagents and conditions: (a) 2-chloroacetyl chloride, CH 2 Cl 2 , K 2 CO 3 , 4 h, rt, 85%-93%; (b) 6-aminobenzothiazole-2-thiol (compound 5), THF, Et 3 N, reflux, 4-6 h; (c) 2-methoxybenzoyl chloride/2-chloroacetyl chloride/3-chloropropanoyl chloride/2-bromoacetyl bromide, Et 3 N, THF, rt, 4-12 h, 63%-91%.
Commercially available amines (compounds 3a-j) were first reacted with 2-chloroacetyl chloride in the presence of potassium carbonate as the base in dichloromethane to give crude compounds 4a-j. The raw products 4a-j were purified by recrystallization from ethyl acetate/petroleum ether. The compounds 6a-j were prepared by reacting 4a-j with 6-aminobenzothiazole-2-thiol (compound 5) and triethylamine (TEA) as the base in tetrahydrofuran (THF) under reflux. Compounds 6a-j respectively were thus obtained and could be used directly for the next step without further purification. The reaction mixtures of compounds 6a-j were further reacted with 3-chloropropyl chloride, 2-bromoacetyl bromide, 2-chloroacetyl chloride and 2-methoxybenzoyl chloride in the presence of triethylamine (TEA), respectively. The precipitates were collected by filtration and washed with water to yield the crude products (compounds 7a-t). Each compound was purified by column chromatography on silica gel using petroleum ether/ethyl acetate as eluent. The structures of all compounds were determined by 1 H-NMR, 13 C-NMR and HRMS (ESI).
Biological Activities
The twenty novel synthesized benzothiazole-2-thiol derivatives were investigated for anticancer activity in vitro on cancer cell lines by the MTT assay with compounds 1 and 2 as positive controls. Compounds 1 and 2 showed good activity against human colon adenocarcinoma cell line (SW480), human cervical cancer cell line (HeLa) and human hepatocellular carcinoma cell line (HepG2) in our preceding studies. Herein, we selected firstly the three human cell lines to test these compounds and the results were presented in Table 1 . These novel compounds showed great variation of IC 50 values on the three cell lines and compounds 7d, 7e, 7f and 7i exhibited potent inhibitory activities. To further study the cytotoxic profile, the potent analogues 7d, 7e, 7f and 7i were selected for further evaluation of inhibitory activities against other eleven types of human cancer cell lines, including colon cancer cell lines HCT-116 and SW620, lung cancer cell line A549, prostate cancer cell line PC-3, pancreatic cancer cell line BxPC-3, breast cancer cell line BT474, epidermoid cancer cell line A431, ovarian cancer cell line SKOV-3, non-small cell lung cancer cell line H460, breast cancer cell line MDA-MB-468 and SKRB-3.
As shown in Table 2 , compounds 7d, 7e, 7f and 7i exhibited potent and broad-spectrum anticancer activities which were much better than compounds 1 and 2. Among them, compound 7d showed the most potent antitumor activities against A431 (IC 50 = 20 nM) and compound 7e displayed the most potent anticancer activity on SKRB-3 (IC 50 = 1.2 nM), SW620 (IC 50 = 4.3 nM), A549 (IC 50 = 44 nM) and HepG2 (IC 50 = 48 nM). The antitumor activities of compounds 7d and 7e were about 10-1,000 times greater than compounds 1 and 2 (SW620, A549, SKRB-3 and HepG2). These results suggested that pyridin-2-amine linking benzothiazole-2-thiol derivatives have potent and broad-spectrum anti-cancer activities and be worth being further investigated as candidate of anticancer agent. In order to investigate the apoptosis effects of the benzothiazole-2-thiol derivatives, we selected compound 7e to examine apoptosis effects on HepG2 cells by flow cytometry. Flow cytometric analysis was performed to measure the apoptotic cells and the cell cycle after propidium iodide (PI) staining [9] . From Figure 1 , the percentages of apoptotic cells were 34.2%, 46.2% and 53.3%, respectively, with 0.625 µM, 1.25 µM, and 2.5 µM compound 7e treatment for 24 h. The results indicated that compound 7e inhibited the proliferation of HepG2 cell via inducing apoptosis on a concentration-dependent manner. The exact and further biological mechanism of compound 7e is under investigation in our laboratory. 
Experimental
General
The human cancer cell lines were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Dulbecco's modified Eagle medium (DMEM) and RPMI 1640 were purchased from Gibco (Grand Island, NY, USA). Fetal bovine serum (FBS) was purchased from Hyclone (Logan, UT, USA). Column chromatography was carried out on silica gel (200-300 mesh, Qingdao Marine Chemical Ltd., Qingdao, China). Thin layer chromatography (TLC) was performed on TLC silica gel 60 F254 plates. Melting points were measured using a on a Kofler hot stage apparatus and were uncorrected. C-NMR spectra were recorded on a Bruker AV II-600 MHz spectrometer. Mass spectrometry was carried out on a Waters Q-TOF Premier mass spectrometer. All solvents were dried and freshly distilled prior to use according to standard procedures. All the chemicals used were of analytical grade and commercially available. The purity of compound screened in biological assays was determined to be ≥90% by HPLC analysis with a photodiode array detector (Waters, Milford, MA, USA). An Atlantis C 18 (150 mm × 4.6 mm, i.d. 5 μm) (Waters) was used with a gradient elution of methanol and HPLC-grade water as mobile phase at a flow rate of 1 mL/min.
Preparation of Compounds 4a-j
Compounds 4a-j were prepared following the literature procedure [10] . 2-Chloroacetyl chloride (0.75 mol) was added dropwise to a mixture of 3a-j (0.5 mol) and potassium carbonate (1.0 mol) in dichloromethane (550 mL) at 0 °C with stirring. After removal of the dichloromethane and vacuum filtration, the solid was washed with water and dried under vacuum for 12 h at 25-30 °C. The title compounds 4a-j were purified by recrystallization with petroleum ether/ethyl acetate.
Preparation of Compounds 6a-j
Compounds 6a-j were synthesized according to a literature method [11] with some modifications. Briefly, 6-aminobenzothiazole-2-thiol (35.0 mmol) was added to a mixture of 4a-j (38.5 mmol) and triethylamine (TEA, 70.0 mmol) in tetrahydrofuran (THF, 480 mL) at room temperature with stirring for 5 h. The title compounds 6a-j were obtained, respectively, and could be used directly for the next step without further purification.
General Procedure for Preparing Compounds 7a-t
The reaction mixtures of compounds 6a-j (3 mmol) were further reacted with acyl chloride (3.6 mmol) in the presence of triethylamine (TEA, 4.5 mmol) using tetrahydrofuran (THF, 30 mL) as solvent. The completion of the reaction was monitored by TLC and took 4-26 h. The precipitate was collected by filtration and washed with water to yield the crude product. Compounds 7a-t were purified by column chromatography on silica gel using petroleum ether/ethyl acetate as eluent. 
N-(2-(2-(Benzylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)-3-chloropropanamide (7a
N-Benzyl-2-(6-(2-bromoacetamido)benzo[d]thiazol-2-ylthio)acetamide (7b
2-Chloro-N-(2-(2-oxo-2-(pyridin-2-ylamino)ethylthio)benzo[d]thiazol-6-yl)acetamide (7c
2-Chloro-N-(2-(2-(5-chloropyridin-2-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)acetamide (7d
N-(5-Bromopyridin-2-yl)-2-(6-(2-chloroacetamido)benzo[d]thiazol-2-ylthio)acetamide (7e
2-Chloro-N-(2-(2-(5-methylpyridin-2-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)acetamide
2-Chloro-N-(2-(2-oxo-2-(pyridin-3-ylamino)ethylthio)benzo[d]thiazol-6-yl)acetamide (7g
2-Chloro-N-(2-(2-(2-chloropyridin-4-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)acetamide (7h
2-Chloro-N-(2-(2-(2-chloro-4-methylpyridin-3-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)acetamide (7i
2-Chloro-N-(2-(2-oxo-2-(pyrimidin-2-ylamino)ethylthio)benzo[d]thiazol-6-yl)acetamide (7j)
. Brownish red powder, yield 63%, purity 90.0%, mp 172.6-174.9 °C; Methoxy-N-(2-(2-oxo-2-(pyridin-2-ylamino) 
2-Chloro-N-(2-(2-oxo-2-(thiazol-2-ylamino)ethylthio)benzo[d]thiazol-6-yl)acetamide (7k
2-
N-(2-(2-(5-Chloropyridin-2-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)-2-methoxybenzamide (7m).
Yellow powder, yield 70%, purity 97.0%, mp 148.5-154.1 °C; 
N-(2-(2-(5-Bromopyridin-2-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)-2-methoxybenzamide (7n
2-Methoxy-N-(2-(2-(5-methylpyridin-2-ylamino)-2-oxoethylthio)benzo[d]thiazol-6-yl)benzamide (7o
2-Methoxy-N-(2-(2-oxo-2-(pyridin-3-ylamino)ethylthio)benzo[d]thiazol-6-yl)benzamide (7p
2-Methoxy-N-(2-(2-oxo-2-(pyrimidin-2-ylamino)ethylthio)benzo[d]thiazol-6-yl)benzamide (7s
2-Methoxy-N-(2-(2-oxo-2-(thiazol-2-ylamino)ethylthio)benzo[d]thiazol-6-yl)benzamide (7t
Cell Culture
Cell lines HepG2, HeLa, HCT116, SW620, SKOV-3 and MDA-MB-468 were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (10 mg/L). Cell lines BT474, A431 and SKRB-3 were maintained in Dulbecco's modified Eagle medium (DMEM) containing 20% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (10 mg/L). Cell lines H460, PC-3, A549, SW480, and BxPC-3 were
